specific effects of long-chain metabolites of vitamin E. *Mol. Nutr. Food Res.* **2017**, *61*, No. 1700562.

(29) Cifolilli, S.; Wallert, M.; Bartolini, D.; Krauth, V.; Werz, O.; Piroddi, M.; Sebastiani, B.; Torquato, P.; Lorkowski, S.; Birringer, M.; Galli, F. Human serum determination and in vitro anti-inflammatory activity of the vitamin E metabolite alpha-(13'-hydroxy)-6-hydroxychroman. *Free Radic. Biol. Med.* **2015**, *89*, 952–962.

(30) Wallert, M.; Schmol, L.; Koeberle, A.; Krauth, V.; Glei, M.; Galli, F.; Werz, O.; Birringer, M.; Lorkowski, S. Alpha-tocopherol long-chain metabolite alpha-13'-COOH affects the inflammatory response of lipopolysaccharide-activated murine RAW264.7 macrophages. *Mol. Nutr. Food Res.* **2015**, *59*, 1524–1534.

(31) Jiang, Q.; Yin, X.; Lill, M. A.; Danielson, M. L.; Freiser, H.; Huang, J. Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases. *Proc. Natl. Acad. Sci. U.S.A.* **2008**, *105*, 20464–20469.

(32) Alsabil, K.; Suor-Cherer, S.; Koeberle, A.; Viault, G.; Lavaud, A.; Temml, V.; Waltenberger, B.; Schuster, D.; Litaudon, M.; Lorkowski, S.; De Vaumas, R.; Helesbeux, J. J.; Guilet, D.; Stuppner, H.; Werz, O.; Seraphin, D.; Richomme, P. Semisynthetic and natural garcinoic acid isoforms as new mPGES-1 inhibitors. *Planta Med.* **2016**, *82*, 1110–1116.

(33) Samuelsson, B.; Morgenstern, R.; Jakobsson, P. J. Membrane prostaglandin e synthase-1: A novel therapeutic target. *Pharmacol. Rev.* **2007**, *59*, 207–224.

(34) Koeberle, A.; Laufer, S. A.; Werz, O. Design and development of microsomal prostaglandin E2 synthase-1 inhibitors: Challenges and future directions. *J. Med. Chem.* **2016**, *59*, 5970–5986.

(35) Wallert, M.; Bauer, J.; Kluge, S.; Schmolz, L.; Chen, Y. C.; Ziegler, M.; Searle, A. K.; Maxones, A.; Schubert, M.; Thurmer, M.; Pein, H.; Koeberle, A.; Werz, O.; Birringer, M.; Peter, K.; Lorkowski, S. The vitamin E derivative garcinoic acid from *Garcinia kola* nut seeds attenuates the inflammatory response. *Redox Biol.* **2019**, *24*, No. 101166.

(36) Koeberle, A.; Northoff, H.; Werz, O. Identification of 5-lipoxygenase and microsomal prostaglandin e2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol. *Biochem. Pharmacol.* **2009**, *77*, 1513–1521.

(37) Reques, F. G.; Rodriguez, J. L. Tolerability of leukotriene modifiers in asthma: A review of clinical experience. *Biodrugs* **1999**, *11*, 385–394.

(38) Alsabil, K.; Viault, G.; Suor-Cherer, S.; Helesbeux, J. J.; Merza, J.; Dumontet, V.; Peña-Rodriguez, L. M.; Richomme, P.; Séraphin, D. Efficient ortho-formylation in vitamin E series, application to the semi-synthesis of natural 5- and 7-formyl-δ-tocotrienols revealing an unprecedented 5-bromo-7-formyl exchange. *Tetrahedron* **2017**, *73*, 6863–6870.

(39) Ville, A.; Viault, G.; Helesbeux, J. J.; Guilet, D.; Richomme, P.; Seraphin, D. Efficient semi-synthesis of natural delta-(r)-tocotrienols from a renewable vegetal source. *J. Nat. Prod.* **2019**, *82*, 51–58.

(40) Terashima, K.; Shimamura, T.; Tanabayashi, M.; Aqil, M.; Akinniyi, J. A.; Niwa, M. Constituents of the seeds of *Garcinia kola*: Two new antioxidants, garcinoic acid and garcinal. *Heterocycles* **1997**, *45*, 1559–1566.

(41) Lavaud, A.; Richomme, P.; Litaudon, M.; Andriantsitohaina, R.; Guilet, D. Antiangiogenic tocotrienol derivatives from *Garcinia amplexicaulis*. *J. Nat. Prod.* **2013**, *76*, 2246–2252.

(42) Dinh, C. P.; Ville, A.; Neukirch, K.; Viault, G.; Temml, V.; Koeberle, A.; Werz, O.; Schuster, D.; Stuppner, H.; Richomme, P.; Helesbeux, J. J.; Seraphin, D. Structure-based design, semi-synthesis and anti-inflammatory activity of tocotrienolic amides as 5-lipoxygenase inhibitors. *Eur. J. Med. Chem.* **2020**, *202*, No. 112518.

(43) Richomme, P.; Helesbeux, J. J.; Guilet, D.; Seraphin, D.; Stuppner, H.; Waltenberger, B.; Schuster, D.; Temml Veronika, S.; Koeberle, A.; Werz, O. Tocotrienol Derivatives, Pharmaceutical Composition and Method of Use in 5-Lipoxygenase Related Diseases. *WO2017/032881A12017*.

(44) Monache, F. D.; Marta, M.; Mac-Quhae, M. M.; Nicoletti, M. Two new tocotrienoloic acids from the fruits of clusia grandiflora splith. *Gazz. Chim. Ital.* **1984**, *114*, 135–137.

(45) Hofsløkken, N. U.; Skattebøl, L.; Johansson, F.; Bertilsson, S. K.; Andersson, P. G.; Møller, J.; Senning, A.; Yao, X.-K.; Wang, H.-G.; Tuchagues, J. P.; Ögren, M. Convenient method for the ortho-formylation of phenols. *Acta Chem. Scand.* **1999**, *53*, 258–262.

(46) Behery, F. A.; Akl, M. R.; Ananthula, S.; Parajuli, P.; Sylvester, P. W.; El Sayed, K. A. Optimization of tocotrienols as antiproliferative and antimigratory leads. *Eur. J. Med. Chem.* **2013**, *59*, 329–341.

(47) Viault, G.; Kempf, M.; Ville, A.; Alsabil, K.; Perrot, R.; Richomme, P.; Helesbeux, J. J.; Seraphin, D. Semisynthetic vitamin E derivatives as potent antibacterial agents against resistant gram-positive pathogens. *ChemMedChem* **2021**, *16*, 881–890.

(48) Dallacker, F.; Eisbach, R.; Holschbach, M. Derivatives in the vitamin E series. Part 1. Synthesis and reactions of all-rac-5-formyl-γ-tocopherol (i). *Chem. Ztg.* **1991**, *115*, 285–289.

(49) Fronza, G.; Fuganti, C.; Serra, S. Stereochemical course of baker's yeast mediated reduction of the tri- and tetrasubstituted double bonds of substituted cinnamaldehydes. *Eur. J. Org. Chem.* **2009**, *2009*, 6160–6171.

(50) Ohtsuka, Y.; Ikeno, T.; Yamada, T. Catalytic enantioselective protonation of cobalt-enolate equivalents generated by 1,4-reduction with borohydride. *Tetrahedron: Asymmetry* **2003**, *14*, 967–970.

(51) Mahoney, W. S.; Brestensky, D. M.; Stryker, J. M. Selective hydride-mediated conjugate reduction of alpha,beta-unsaturated carbonyl-compounds using [(ph3p)cuh]6. *J. Am. Chem. Soc.* **1988**, *110*, 291–293.

(52) Kwon Youn, I.; Hwan Yon, G.; Siek Pak, C. Magnesium-methanol as a simple convenient reducing agent for α,β-unsaturated esters. *Tetrahedron Lett.* **1986**, *27*, 2409–2410.

(53) Lee, G. H.; Youn, I. K.; Choi, E. B.; Lee, H. K.; Yon, G. H.; Yang, H. C.; Pak, C. S. Magnesium in methanol (Mg/MeOH) in organic syntheses. *Curr. Org. Chem.* **2004**, *8*, 1263–1287.

(54) Terashima, K.; Takaya, Y.; Niwa, M. Powerful antioxidative agents based on garcinoic acid from *Garcinia kola*. *Bioorg. Med. Chem.* **2002**, *10*, 1619–1625.

(55) Furstner, A. Olefin metathesis and beyond. *Angew. Chem., Int. Ed.* **2000**, *39*, 3012–3043.

(56) Ville, A. Métabolites secondaires et analogues hémisynthétiques en série vitaminique E: Obtention et évaluation du potentiel antiinflammatoire. *Dissertation, University of Angers*, 2018.

(57) Gujarathi, S.; Zafar, M. K.; Liu, X.; Eoff, R. L.; Zheng, G. A facile semisynthesis and evaluation of garcinoic acid and its analogs for the inhibition of human DNA polymerase beta. *Molecules* **2020**, *25*, No. 5847.

(58) Roman, G. Mannich bases in medicinal chemistry and drug design. *Eur. J. Med. Chem.* **2015**, *89*, 743–816.

(59) Maria, K.; Dimitra, H. L.; Maria, G. Synthesis and anti-inflammatory activity of chalcones and related mannich bases. *Med. Chem.* **2008**, *4*, 586–596.

(60) Chen, W.; Park, S. K.; Yu, W.; Xiong, A.; Sanders, B. G.; Kline, K. Synthesis and screening of novel vitamin E derivatives for anticancer functions. *Eur. J. Med. Chem.* **2012**, *58*, 72–83.

(61) Behery, F. A.; Elnagar, A. Y.; Akl, M. R.; Wali, V. B.; Abuasal, B.; Kaddoumi, A.; Sylvester, P. W.; El Sayed, K. A. Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors. *Bioorg. Med. Chem.* **2010**, *18*, 8066–8075.

(62) Werz, O. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin. *Planta Med.* **2007**, *73*, 1331–1357.

(63) Locowicz, J. *Principles of Fluorescence Spectroscopy*, 3rd ed.; Springer, 2006.

(64) Jiang, Z.; Yin, X.; Jiang, Q. Natural forms of vitamin E and 13'-carboxychromanol, a long-chain vitamin E metabolite, inhibit leukotriene generation from stimulated neutrophils by blocking calcium influx and suppressing 5-lipoxygenase activity, respectively. *J. Immunol.* **2011**, *186*, 1173–1179.
(65) Koeberle, A.; Werz, O. Multi-target approach for natural products in inflammation. *Drug Discovery Today* **2014**, *19*, 1871–1882.

(66) Shimizu, T. Lipid mediators in health and disease: Enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. *Annu. Rev. Pharmacol. Toxicol.* **2009**, *49*, 123–150.

(67) Yanes, D. A.; Mosser-Goldfarb, J. L. Emerging therapies for atopic dermatitis: The prostaglandin/leukotriene pathway. *J. Am. Acad. Dermatol.* **2018**, *78*, S71–S75.

(68) Dainichi, T.; Kitoh, A.; Otsuka, A.; Nakajima, S.; Nomura, T.; Kaplan, D. H.; Kabashima, K. The epithelial immune microenvironment (eime) in atopic dermatitis and psoriasis. *Nat. Immunol.* **2018**, *19*, 1286–1298.

(69) Siracusa, M. C.; Saenz, S. A.; Hill, D. A.; Kim, B. S.; Headley, M. B.; Doering, T. A.; Wherry, E. J.; Jessup, H. K.; Siegel, L. A.; Kambayashi, T.; Dudek, E. C.; Kubo, M.; Cianferoni, A.; Spergel, J. M.; Ziegler, S. F.; Comeau, M. R.; Artis, D. Tslp promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. *Nature* **2011**, *477*, 229–233.

(70) Weidinger, S.; Beck, L. A.; Bieber, T.; Kabashima, K.; Irvine, A. D. Atopic dermatitis. *Nat. Rev. Dis. Primers* **2018**, *4*, No. 1.

(71) Hachem, J. P.; Crumrine, D.; Fluhr, J.; Brown, B. E.; Feingold, K. R.; Elias, P. M. Ph directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. *J. Invest. Dermatol.* **2003**, *121*, 345–353.

(72) Hanke, T.; Dehm, F.; Liening, S.; Popella, S. D.; Maczewsky, J.; Pillong, M.; Kunze, J.; Weinigel, C.; Barz, D.; Kaiser, A.; Wurglics, M.; Lammerhofer, M.; Schneider, G.; Sautebin, L.; Schubert-Zsilavecz, M.; Werz, O. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin e2 synthase-1 inhibitors with improved potency and efficiency in vivo. *J. Med. Chem.* **2013**, *56*, 9031–9044.

(73) Yokomizo, T.; Nakamura, M.; Shimizu, T. Leukotriene receptors as potential therapeutic targets. *J. Clin. Invest.* **2018**, *128*, 2691–2701.

(74) Diez-Roux, G.; Ballabio, A. Sulfatases and human disease. *Annu. Rev. Genomics Hum. Genet.* **2005**, *6*, 355–379.

(75) Fischer, L.; Szellas, D.; Radmark, O.; Steinhilber, D.; Werz, O. Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors. *FASEB J.* **2003**, *17*, 949–951.

(76) Pergola, C.; Dodt, G.; Rossi, A.; Neunhoeffer, E.; Lawrenz, B.; Northoff, H.; Samuelsson, B.; Radmark, O.; Sautebin, L.; Werz, O. Erk-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma. *Proc. Natl. Acad. Sci. U.S.A.* **2008**, *105*, 19881–19886.

(77) Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.; Taylor, R. D. Improved protein-ligand docking using gold. *Proteins* **2003**, *52*, 609–623.

(78) Gilbert, N. C.; Bartlett, S. G.; Waight, M. T.; Neau, D. B.; Boeglin, W. E.; Brash, A. R.; Newcomer, M. E. The structure of human 5-lipoxygenase. *Science* **2011**, *331*, 217–219.

(79) Guner, O.; Clement, O.; Kurogi, Y. Pharmacophore modeling and three dimensional database searching for drug design using catalyst: Recent advances. *Curr. Med. Chem.* **2004**, *11*, 2991–3005.

(80) Wolber, G.; Langer, T. Ligandscout: 3-d pharmacophores derived from protein-bound ligands and their use as virtual screening filters. *J. Chem. Inf. Model.* **2005**, *45*, 160–169.

(81) Koeberle, A.; Munoz, E.; Appendino, G. B.; Minassi, A.; Pace, S.; Rossi, A.; Weinigel, C.; Barz, D.; Sautebin, L.; Caprioglio, D.; Collado, J. A.; Werz, O. Sar studies on curcumin's pro-inflammatory targets: Discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase. *J. Med. Chem.* **2014**, *57*, 5638–5648.

(82) Liedtke, A. J.; Keck, P. R.; Lehmann, F.; Koeberle, A.; Werz, O.; Laufer, S. A. Arylpyrrolizines as inhibitors of microsomal prostaglandin e2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX). *J. Med. Chem.* **2009**, *52*, 4968–4972.

(83) Garscha, U.; Romp, E.; Pace, S.; Rossi, A.; Temml, V.; Schuster, D.; Konig, S.; Gerstmeier, J.; Liening, S.; Werner, M.; Atze, H.; Wittmann, S.; Weinigel, C.; Rummler, S.; Scriba, G. K.; Sautebin, L.; Werz, O. Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase. *Sci. Rep.* **2017**, *7*, No. 9398.

(84) Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. *Genome Res.* **2003**, *13*, 2498–2504.

(85) Raasch, M.; Rennert, K.; Jahn, T.; Peters, S.; Henkel, T.; Huber, O.; Schulz, I.; Becker, H.; Lorkowski, S.; Funke, H.; Mosig, A. Microfluidically supported biochip design for culture of endothelial cell layers with improved perfusion conditions. *Biofabrication* **2015**, *7*, No. 015013.

(86) Raasch, M.; Rennert, K.; Jahn, T.; Gartner, C.; Schonfelder, G.; Huber, O.; Seiler, A. E.; Mosig, A. S. An integrative microfluidically supported in vitro model of an endothelial barrier combined with cortical spheroids simulates effects of neuroinflammation in neocortex development. *Biomicrofluidics* **2016**, *10*, No. 044102.

(87) Jaffe, E. A.; Nachman, R. L.; Becker, C. G.; Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. *J. Clin. Invest.* **1973**, *52*, 2745–2756.

(88) Pendaries, V.; Malaisse, J.; Pellerin, L.; Le Lamer, M.; Nachat, R.; Kezic, S.; Schmitt, A. M.; Paul, C.; Poumay, Y.; Serre, G.; Simon, M. Knockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiation. *J. Invest. Dermatol.* **2014**, *134*, 2938–2946.

(89) Pendaries, V.; Lamer, Le.; Cau, M.; Hansmann, L.; Malaisse, B.; Kezic, J.; Serre, S.; Simon, G. M. In a three-dimensional reconstructed human epidermis filaggrin-2 is essential for proper cornification. *Cell Death Dis.* **2015**, *6*, No. e1656.

(90) Reynier, M.; Allart, S.; Gaspard, E.; Moga, A.; Goudouneche, D.; Serre, G.; Simon, M.; Leprince, C. Rab11a is essential for lamellar body biogenesis in the human epidermis. *J. Invest. Dermatol.* **2016**, *136*, 1199–1209.